|
|
|
Insider
Information: |
Muehl Daniel W |
Relationship: |
See Remarks |
City: |
North Billerca |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
114,830 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,583,172 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
114,830 |
|
|
Total
Value |
$1,583,172 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
26
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
23
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-1,216.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Repligen Corp |
RGEN |
CFO |
2006-01-19 |
10,000 |
2006-01-19 |
0 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
See Remarks |
2022-11-02 |
104,830 |
2017-03-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-08-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,624 |
31,539 |
0 |
- |
|
RGEN |
Repligen Corp |
officerTitle |
|
2006-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,248 |
56,425 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,248 |
69,130 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,248 |
90,064 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,248 |
106,896 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,249 |
63,084 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,249 |
98,432 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,250 |
74,670 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-02-04 |
4 |
S |
$8.41 |
$88,070 |
D/D |
(10,472) |
21,959 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-03-02 |
4 |
S |
$1.87 |
$19,977 |
D/D |
(10,706) |
82,324 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-02-02 |
4 |
S |
$7.97 |
$94,620 |
D/D |
(11,872) |
46,990 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,813 |
92,740 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,497 |
27,388 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,125 |
56,244 |
0 |
- |
|
90 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|